Thermo Fisher Scientific announced earnings per share of $3.89 on revenue of $6.92B. Analysts polled by Investing.com anticipated EPS of $2.78 on revenue of $5.87B.
Thermo Fisher Scientific shares are up 24% from the beginning of the year , still down 1.61% from its 52 week high of $409.69 set on July 21. They are outperforming the S&P 500 which is up 0.82% from the start of the year.
Thermo Fisher Scientific’s report follows an earnings beat by J&J on July 16, who reported EPS of $1.67 on revenue of $18.34B, compared to forecasts EPS of $1.49 on revenue of $17.61B.
Novartis ADR had beat expectations on Tuesday with second quarter EPS of $1.36 on revenue of $11.35B, compared to forecast for EPS of $1.34 on revenue of $11.9B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar